IO Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
IO Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- IO Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.64M, a 1.11% increase year-over-year.
- IO Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.76M, a 2.4% increase year-over-year.
- IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.06M, a 14.5% increase from 2022.
- IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 293% increase from 2021.
- IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.79M, a 2698% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)